NEW YORK (360Dx) – Saladax Biomedical today announced an agreement to acquire the exclusive patent rights for antipsychotic drug tests from Janssen Pharmaceutica.

Saladax will have the patent rights to Janssen Pharmaceutica's diagnostic tests that determine drug levels in patients undergoing treatment with antipsychotic drugs. Financial and other terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.